Twist Bioscience (NASDAQ:TWST) Price Target Increased to $48.00 by Analysts at Scotiabank

Twist Bioscience (NASDAQ:TWST – Get Free Report) had its price target lifted by Scotiabank from $43.00 to $48.00 in a report released on Monday, Benzinga reports. The brokerage presently has a “sector outperform” rating on the stock. Scotiabank’s price objective would indicate a potential upside of 7.43% from the company’s current price. Several other equities […]

Related Keywords

United Kingdom ,Robertw Baird ,Emilym Leproust , ,Twist Bioscience Company Profile ,Securities Exchange Commission ,Barclays ,Artisan Partners Limited Partnership ,Invesco Ltd ,Investment Management ,Goldman Sachs Group ,Twist Bioscience Corporation ,Norges Bank ,Nasdaq ,Scotiabank ,United Kingdom Plc ,Twist Bioscience ,Get Free Report ,Exchange Commission ,Partners Limited Partnership ,Kingdom Plc ,Bioscience Corporation ,Twist Bioscience Daily ,Nasdaq Twst ,Twst ,Medical ,Boost Price Target ,